Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes
暂无分享,去创建一个
Stefanie Dimmeler | Rüdiger Popp | R. Busse | R. Brandes | A. Zeiher | S. Dimmeler | C. Urbich | I. Fleming | C. Badorff | R. Popp | A. Aicher | Carmen Urbich | Ingrid Fleming | Andreas M Zeiher | Ralf P Brandes | Alexandra Aicher | S. Rupp | Rudi Busse | Cornel Badorff | Stefan Rupp
[1] A M Wobus,et al. Selection of ventricular‐like cardiomyocytes from ES cells in vitro , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[3] S. Fichtlscherer,et al. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.
[4] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[5] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[6] R. Mulligan,et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.
[7] B. Christy,et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.
[8] J. Hescheler,et al. Characteristics of calcium sparks in cardiomyocytes derived from embryonic stem cells. , 2001, American journal of physiology. Heart and circulatory physiology.
[9] S. Rafii,et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.
[10] E. Topol,et al. Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling. , 2001, Circulation research.
[11] P. McNutt,et al. Cadherins and their connections: adhesion junctions have broader functions. , 1999, Current opinion in cell biology.
[12] G. Cossu,et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Isner,et al. Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.
[14] K. Pantel,et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.
[15] J. Isner,et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.
[16] L Gepstein,et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.
[17] T. Murohara,et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.
[18] L. Sauvage,et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. , 2000, Blood.
[19] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Wang,et al. Changing potency by spontaneous fusion , 2022 .
[21] S. Ogawa,et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.
[22] A. Zeiher,et al. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. , 2002, The Journal of clinical investigation.
[23] S. Fichtlscherer,et al. Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.
[24] A M Zeiher,et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.